Neutralase heparin neutralizer: IBT announced interim results of its Phase II trial of Neutralase to neutralize heparin's anticoagulant effect during surgery in

Ibex Technologies Inc. (TSE:IBT), Montreal, Quebec
Product: Neutralase heparin

Read the full 96 word article

How to gain access

Continue reading with a
two-week free trial.